Proquin XR Depomed, Inc. - Treatment for Uncomplicated Urinary Tract Infections

Proquin XR a once-daily, extended-release formulation of ciprofloxacin hydrochloride designed to reduce gastrointestinal side effects such as nausea and diarrhea. Proquin XR is indicated for the treatment of uncomplicated urinary tract infections (UTIs).

Related Articles:

Depomed Announces Proquin XR NDA Accepted by FDA - September 20, 2004

Latest FDA Drug Approvals...

2008: Jan | Feb | Mar | Apr | May | Jun | Jul
2007: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2006: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2005: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2004: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2003: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2002: Oct | Dec

Daily MedNews
Pharma Industry News
New Drug Applications
New Drug Approvals
Clinical Trial Results
Generic Drug Approvals